United States Neuromodulation Devices Market Report 2016

December 2016 | 103 pages | ID: U56A2323E5DEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Neuromodulation Devices

Revenue, means the sales value of Neuromodulation Devices

This report studies sales (consumption) of Neuromodulation Devices in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Medtronic, Inc.
• Boston Scientific Corporation
• St. Jude Medical, Inc
• Synapse Biomedical, Inc.
• Nevro Corporation
• Neurosigma, Inc.
• Neuropace, Inc.
• Neuronetics, Inc.
• Cyberonics, Inc.
• BioControl Medical

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Deep Brain Stimulation (DBS) Systems
• Spinal Cord Stimulator (SCS) Systems
• Diaphragm Pacing System (DPS)
• Respiratory Electrical Stimulation (RES)
• Vagus Nerve Stimulation (VNS)
• Gastric Electrical Stimulation (GES)
• Transcranial Magnetic Stimulation (TMS)
• Transcutaneous Electrical Nerve Stimulation (TENS)

Split by applications, this report focuses on sales, market share and growth rate of Neuromodulation Devices in each application, can be divided into

• Chronic Pain
• Parkinson's disease
• Urine Incontinence
• Epilepsy
• Others

Contents

United States Neuromodulation Devices Market Report 2016

1 NEUROMODULATION DEVICES OVERVIEW

1.1 Product Overview and Scope of Neuromodulation Devices
1.2 Classification of Neuromodulation Devices
  1.2.1 Deep Brain Stimulation (DBS) Systems
  1.2.2 Spinal Cord Stimulator (SCS) Systems
  1.2.3 Diaphragm Pacing System (DPS)
  1.2.4 Respiratory Electrical Stimulation (RES)
  1.2.5 Vagus Nerve Stimulation (VNS)
  1.2.6 Gastric Electrical Stimulation (GES)
  1.2.7 Transcranial Magnetic Stimulation (TMS)
  1.2.8 Transcutaneous Electrical Nerve Stimulation (TENS)
1.3 Application of Neuromodulation Devices
  1.3.1 Chronic Pain
  1.3.2 Parkinson's disease
  1.3.3 Urine Incontinence
  1.3.4 Epilepsy
  1.3.5 Others
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Neuromodulation Devices (2011-2021)
  1.4.1 United States Neuromodulation Devices Sales and Growth Rate (2011-2021)
  1.4.2 United States Neuromodulation Devices Revenue and Growth Rate (2011-2021)

2 UNITED STATES NEUROMODULATION DEVICES COMPETITION BY MANUFACTURERS

2.1 United States Neuromodulation Devices Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Neuromodulation Devices Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Neuromodulation Devices Average Price by Manufactures (2015 and 2016)
2.4 Neuromodulation Devices Market Competitive Situation and Trends
  2.4.1 Neuromodulation Devices Market Concentration Rate
  2.4.2 Neuromodulation Devices Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES NEUROMODULATION DEVICES SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Neuromodulation Devices Sales and Market Share by Type (2011-2016)
3.2 United States Neuromodulation Devices Revenue and Market Share by Type (2011-2016)
3.3 United States Neuromodulation Devices Price by Type (2011-2016)
3.4 United States Neuromodulation Devices Sales Growth Rate by Type (2011-2016)

4 UNITED STATES NEUROMODULATION DEVICES SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Neuromodulation Devices Sales and Market Share by Application (2011-2016)
4.2 United States Neuromodulation Devices Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES NEUROMODULATION DEVICES MANUFACTURERS PROFILES/ANALYSIS

5.1 Medtronic, Inc.
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Neuromodulation Devices Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Medtronic, Inc. Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Boston Scientific Corporation
  5.2.2 Neuromodulation Devices Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Boston Scientific Corporation Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 St. Jude Medical, Inc
  5.3.2 Neuromodulation Devices Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 St. Jude Medical, Inc Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Synapse Biomedical, Inc.
  5.4.2 Neuromodulation Devices Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Synapse Biomedical, Inc. Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Nevro Corporation
  5.5.2 Neuromodulation Devices Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Nevro Corporation Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Neurosigma, Inc.
  5.6.2 Neuromodulation Devices Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Neurosigma, Inc. Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Neuropace, Inc.
  5.7.2 Neuromodulation Devices Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Neuropace, Inc. Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Neuronetics, Inc.
  5.8.2 Neuromodulation Devices Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Neuronetics, Inc. Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Cyberonics, Inc.
  5.9.2 Neuromodulation Devices Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Cyberonics, Inc. Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 BioControl Medical
  5.10.2 Neuromodulation Devices Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 BioControl Medical Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview

6 NEUROMODULATION DEVICES MANUFACTURING COST ANALYSIS

6.1 Neuromodulation Devices Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Neuromodulation Devices

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Neuromodulation Devices Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Neuromodulation Devices Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES NEUROMODULATION DEVICES MARKET FORECAST (2016-2021)

10.1 United States Neuromodulation Devices Sales, Revenue Forecast (2016-2021)
10.2 United States Neuromodulation Devices Sales Forecast by Type (2016-2021)
10.3 United States Neuromodulation Devices Sales Forecast by Application (2016-2021)
10.4 Neuromodulation Devices Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Neuromodulation Devices
Table Classification of Neuromodulation Devices
Figure United States Sales Market Share of Neuromodulation Devices by Type in 2015
Figure Deep Brain Stimulation (DBS) Systems Picture
Figure Spinal Cord Stimulator (SCS) Systems Picture
Figure Diaphragm Pacing System (DPS) Picture
Figure Respiratory Electrical Stimulation (RES) Picture
Figure Vagus Nerve Stimulation (VNS) Picture
Figure Gastric Electrical Stimulation (GES) Picture
Figure Transcranial Magnetic Stimulation (TMS) Picture
Figure Transcutaneous Electrical Nerve Stimulation (TENS) Picture
Table Application of Neuromodulation Devices
Figure United States Sales Market Share of Neuromodulation Devices by Application in 2015
Figure Chronic Pain Examples
Figure Parkinson's disease Examples
Figure Urine Incontinence Examples
Figure Epilepsy Examples
Figure Others Examples
Figure United States Neuromodulation Devices Sales and Growth Rate (2011-2021)
Figure United States Neuromodulation Devices Revenue and Growth Rate (2011-2021)
Table United States Neuromodulation Devices Sales of Key Manufacturers (2015 and 2016)
Table United States Neuromodulation Devices Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Neuromodulation Devices Sales Share by Manufacturers
Figure 2016 Neuromodulation Devices Sales Share by Manufacturers
Table United States Neuromodulation Devices Revenue by Manufacturers (2015 and 2016)
Table United States Neuromodulation Devices Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Neuromodulation Devices Revenue Share by Manufacturers
Table 2016 United States Neuromodulation Devices Revenue Share by Manufacturers
Table United States Market Neuromodulation Devices Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Neuromodulation Devices Average Price of Key Manufacturers in 2015
Figure Neuromodulation Devices Market Share of Top 3 Manufacturers
Figure Neuromodulation Devices Market Share of Top 5 Manufacturers
Table United States Neuromodulation Devices Sales by Type (2011-2016)
Table United States Neuromodulation Devices Sales Share by Type (2011-2016)
Figure United States Neuromodulation Devices Sales Market Share by Type in 2015
Table United States Neuromodulation Devices Revenue and Market Share by Type (2011-2016)
Table United States Neuromodulation Devices Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Neuromodulation Devices by Type (2011-2016)
Table United States Neuromodulation Devices Price by Type (2011-2016)
Figure United States Neuromodulation Devices Sales Growth Rate by Type (2011-2016)
Table United States Neuromodulation Devices Sales by Application (2011-2016)
Table United States Neuromodulation Devices Sales Market Share by Application (2011-2016)
Figure United States Neuromodulation Devices Sales Market Share by Application in 2015
Table United States Neuromodulation Devices Sales Growth Rate by Application (2011-2016)
Figure United States Neuromodulation Devices Sales Growth Rate by Application (2011-2016)
Table Medtronic, Inc. Basic Information List
Table Medtronic, Inc. Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Medtronic, Inc. Neuromodulation Devices Sales Market Share (2011-2016)
Table Boston Scientific Corporation Basic Information List
Table Boston Scientific Corporation Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boston Scientific Corporation Neuromodulation Devices Sales Market Share (2011-2016)
Table St. Jude Medical, Inc Basic Information List
Table St. Jude Medical, Inc Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
Table St. Jude Medical, Inc Neuromodulation Devices Sales Market Share (2011-2016)
Table Synapse Biomedical, Inc. Basic Information List
Table Synapse Biomedical, Inc. Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
Table Synapse Biomedical, Inc. Neuromodulation Devices Sales Market Share (2011-2016)
Table Nevro Corporation Basic Information List
Table Nevro Corporation Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
Table Nevro Corporation Neuromodulation Devices Sales Market Share (2011-2016)
Table Neurosigma, Inc. Basic Information List
Table Neurosigma, Inc. Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
Table Neurosigma, Inc. Neuromodulation Devices Sales Market Share (2011-2016)
Table Neuropace, Inc. Basic Information List
Table Neuropace, Inc. Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
Table Neuropace, Inc. Neuromodulation Devices Sales Market Share (2011-2016)
Table Neuronetics, Inc. Basic Information List
Table Neuronetics, Inc. Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
Table Neuronetics, Inc. Neuromodulation Devices Sales Market Share (2011-2016)
Table Cyberonics, Inc. Basic Information List
Table Cyberonics, Inc. Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cyberonics, Inc. Neuromodulation Devices Sales Market Share (2011-2016)
Table BioControl Medical Basic Information List
Table BioControl Medical Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2011-2016)
Table BioControl Medical Neuromodulation Devices Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Neuromodulation Devices
Figure Manufacturing Process Analysis of Neuromodulation Devices
Figure Neuromodulation Devices Industrial Chain Analysis
Table Raw Materials Sources of Neuromodulation Devices Major Manufacturers in 2015
Table Major Buyers of Neuromodulation Devices
Table Distributors/Traders List
Figure United States Neuromodulation Devices Production and Growth Rate Forecast (2016-2021)
Figure United States Neuromodulation Devices Revenue and Growth Rate Forecast (2016-2021)
Table United States Neuromodulation Devices Production Forecast by Type (2016-2021)
Table United States Neuromodulation Devices Consumption Forecast by Application (2016-2021)